Ablynx Overview
- Year Founded
-
2001

- Status
-
Acquired/Merged
- Employees
-
438

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$4.72B
Ablynx General Information
Description
Manufacturer of biopharmaceutical products created to offer proteins based therapeutics for treatment of inflammation, hematology, immuno-oncology, oncology and respiratory diseases. The company's biopharmaceutical products comprises of their patented product named, Nanobodies that is a therapeutic proteins based on single-chain antibody fragments that combine the benefits of drugs based on conventional antibodies and small chemical molecules, enabling patients avail various therapeutic and new drugs that can make a clear difference to society.
Contact Information
Website
www.ablynx.comCorporate Office
- Technologiepark 21
- 9052 Ghent
- Belgium
Corporate Office
- Technologiepark 21
- 9052 Ghent
- Belgium
Ablynx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
14. Merger/Acquisition | 14-May-2018 | $4.72B | Completed | Profitable | ||
13. Merger/Acquisition | 01-Dec-2017 | Cancelled | Profitable | |||
12. 2PO | 25-Oct-2017 | Completed | Profitable | |||
11. PIPE | 04-Oct-2017 | Completed | Profitable | |||
10. Secondary Transaction - Open Market | 03-Nov-2016 | Completed | Profitable | |||
9. PIPE | 01-Jun-2016 | Completed | Profitable | |||
8. Secondary Transaction - Open Market | 18-Oct-2013 | Completed | Generating Revenue | |||
7. 2PO | 16-Mar-2010 | Completed | Generating Revenue | |||
6. IPO | 07-Nov-2007 | $108M | $196M | Completed | Generating Revenue | |
5. Later Stage VC (Series C) | 23-Aug-2006 | $51.2M | $88.2M | Completed | Generating Revenue |
Ablynx Comparisons
Industry
Financing
Details
Ablynx Competitors (76)
One of Ablynx’s 76 competitors is Krystal Biotech, a Formerly VC-backed company based in Pittsburgh, PA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Krystal Biotech | Formerly VC-backed | Pittsburgh, PA | ||||
Arrowhead Pharmaceuticals | Corporation | Pasadena, CA | ||||
Abeona Therapeutics | Corporation | Cleveland, OH | ||||
Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
vTv Therapeutics | Formerly PE-Backed | High Point, NC |
Ablynx Patents
Ablynx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250154262-A1 | Fc domain variants with enhanced fc receptor binding | Pending | 25-Oct-2023 | ||
US-20240209107-A1 | Cd28/ox40 bispecific antibodies | Active | 10-Oct-2023 | ||
US-12195546-B2 | Cd28/ox40 bispecific antibodies | Active | 10-Oct-2023 | ||
US-20250129145-A1 | Bi- and multivalent albumin binders | Pending | 22-Sep-2023 | ||
US-20240368250-A1 | Polypeptides binding to the neonatal fc receptor | Pending | 17-Feb-2023 | C07K14/765 |
Ablynx Signals
Ablynx Former Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Abingworth | Venture Capital | Minority | ||
Alta Partners | Venture Capital | Minority | ||
Fidelity Management & Research Company | Asset Manager | Minority | ||
Gilde Healthcare | Venture Capital | Minority | ||
Gimv | PE/Buyout | Minority |
Ablynx ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Pharmaceuticals
Industry
Rank
Percentile

Pharmaceuticals
Subindustry
Rank
Percentile

Ablynx FAQs
-
When was Ablynx founded?
Ablynx was founded in 2001.
-
Where is Ablynx headquartered?
Ablynx is headquartered in Ghent, Belgium.
-
What is the size of Ablynx?
Ablynx has 438 total employees.
-
What industry is Ablynx in?
Ablynx’s primary industry is Biotechnology.
-
Is Ablynx a private or public company?
Ablynx is a Private company.
-
What is the current valuation of Ablynx?
The current valuation of Ablynx is
. -
What is Ablynx’s current revenue?
The current revenue for Ablynx is
. -
How much funding has Ablynx raised over time?
Ablynx has raised $578M.
-
Who are Ablynx’s investors?
Abingworth, Alta Partners, Fidelity Management & Research Company, Gilde Healthcare, and Gimv are 5 of 10 investors who have invested in Ablynx.
-
Who are Ablynx’s competitors?
Krystal Biotech, Arrowhead Pharmaceuticals, Abeona Therapeutics, Adaptimmune Therapeutics, and vTv Therapeutics are some of the 76 competitors of Ablynx.
-
When was Ablynx acquired?
Ablynx was acquired on 14-May-2018.
-
Who acquired Ablynx?
Ablynx was acquired by Sanofi.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »